Contra-indicated in patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes.
- TRADE NAMES: Amerge (GSK); Naramig (GSK)
- INDICATIONS: Acute migraine attacks
- CLASS: 5-HT1 agonist, Serotonin receptor antagonist, Triptan
- HALF-LIFE: 6 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
5-HT1 agonists, Dihydroergotamine, Duloxetine, Ergotamine, Methysergide, Metoclopramide, Oral Contraceptives, Rizatriptan, Selegiline, Sibutramine, SNRIs, SSRIs, St John's Wort, Sumatriptan, Triptans, Venlafaxine, Zolmitriptan
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
